Study record · PEG-MGF
FDA evidence audit: PEG-MGF human exposure
FDA states it has not identified human exposure data for drug products containing PEG-MGF.
Key result
FDA states it has not identified human exposure data for drug products containing PEG-MGF.
Study details
Study designRegulatory evidence review / no human exposure identified
PopulationNo human drug-product exposure identified
RouteAny
Regimen / exposureNot applicable
DurationNot applicable
ComparatorNot applicable
Primary endpoint / questionExistence of human exposure and safety data
Safety resultHuman safety cannot be characterized.
Key limitationsPublished MGF peptide biology does not establish exposure or efficacy of the PEGylated product.
Registry / identifierFDA compounding safety review